SEARCH NEWS & VIEWS


New Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
TSRI Chemist Wins NIH Director’s Pioneer Award of $4.8 Million
Snapshot: Margaret Hellwarth

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
New Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology

TSRI’s Scripps Center for Metabolomics reveals a technology used in thousands of labs fundamentally alters the samples it analyzes.

TSRI Chemist Wins NIH Director’s Pioneer Award of $4.8 Million

Professor Matthew Disney is one of only 13 recipients of a Pioneer Award for this year.

Snapshot: Margaret Hellwarth

Meet Margaret Hellwarth, international services manager.

  • Team Identifies Potential Target for Individualized Treatment of Autism Spectrum Disorder
  • Researchers Identify Promising Drug Candidate to Treat Chronic Itch that Avoids Side Effects
  • Scientists Identify a Key Morphine Regulator that May Reduce Risk of Pain-Killer Abuse and Addiction
  • Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President
  • TSRI and UC San Diego Launch New Consortium to Create ‘Virtual Cell’
  • Institute Receives $5.65 Million Gift from San Diego Philanthropist Helen Dorris
  • Institute Receives $12.5 Million Challenge Gift
  • Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
  • Scientists Show How Aging Cripples the Immune System, Suggesting Benefits of Antioxidants
  • Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies
  • International Team Discovers the Ancient Origins of Deadly Lassa Virus
  • Team Makes Strides in Therapy Preventing Addiction Relapse by Erasing Drug-Associated Memories
  • Technology Meets Teamwork: Andrew Ward Unlocks Viruses’ Secrets
  • Team Finds New Antibody Weapons against Marburg Virus
  • Scientists Pinpoint Mechanism for Altered Pattern of Brain Growth in Autism Spectrum Disorder